Clinical Trials & Research at VCCRC
Every breakthrough in cancer care begins with research — and every research study begins with hope. Our Clinical Trials and Research Division drives innovation that transforms treatment, prevention, and patient wellbeing.
Clinical trials are how doctors discover safer, more effective treatments. Patients who participate gain early access to cutting-edge therapies — while helping advance medicine for future generations.
- Medical Oncology Research – testing next-generation chemo, immuno, and targeted therapies.
- Radiation Oncology Innovations – exploring precision techniques for safer treatment.
- Surgical Oncology Trials – improving recovery through minimally invasive approaches.
- Molecular & Genetic Research – identifying genetic markers for personalized care.
- Quality of Life & Survivorship – ensuring every patient thrives beyond treatment.
- Community-Based Studies – addressing cancer challenges unique to our region.
Every clinical trial at VCCRC follows strict ethical standards guided by Kenya’s NACOSTI and international research protocols. Our Institutional Ethics and Research Committee ensures safety, confidentiality, and informed consent at every step.
We partner with universities, pharmaceutical innovators, and international research centers to accelerate discovery and bring world-class science to our community. Together, we’re bridging hope and healing.
Joining a clinical trial is always voluntary. Our team takes time to explain each study clearly — its goals, potential benefits, risks, and your rights — so you can decide confidently and comfortably.
- Comprehensive evaluation and continuous follow-up.
- Access to innovative, leading-edge treatment options.
- Personal guidance from research coordinators and oncologists.
- No compromise on your standard of care.
Ongoing & Future Studies
Explore groundbreaking research now underway at Victoria Cancer Care and Research Centre — studies that bring hope, innovation, and care closer to every patient.
Ongoing Study
A Randomized, Placebo-Controlled Study evaluating clearance of high-risk HPV and safety after administration of ABI-2280 Vaginal Inserts.
Upcoming Studies
- Phase II study targeting HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia.
- Integrated Phase1/3 biosimilar study in Non-Small Cell Lung Cancer (NSCLC).
- Phase 3 Vaccine/Sickle Cell Disease study.
- Phase Ib/II trial evaluating BNT324 with BNT327 in advanced lung cancer.
We envision a future where every patient benefits from research. Through ongoing trials, we’re transforming today’s experimental treatments into tomorrow’s standard of care — extending lives, improving wellbeing, and nurturing hope.
Join Us in Advancing Cancer Research
Whether you are a patient, caregiver, researcher, or healthcare partner — your involvement helps us move closer to a world where cancer is preventable, treatable, and ultimately curable.
📞 Contact Our Clinical Research Office
Email: info@victoriaoncology.com | Phone: +254 795 064 222
Mon–Fri, 8:00 AM – 5:00 PM